Abstract
Background
This study evaluated the feasibility of thoracoscopic thymectomy (TT) for the treatment of early- and advanced-stage thymoma and compared patient outcomes with those following open thymectomy (OT).
Methods
A retrospective review was conducted for 140 patients who underwent TT or OT for Masaoka stage I–IV thymoma between 1996 and 2014.
Results
TT was performed in 88 patients and OT in 52 patients. The postoperative hospital stay was significantly shorter in the TT group than in the OT group (4 and 13 days, respectively; P < 0.0001). WHO types B3–C were identified in Masaoka stage III–IV disease with high frequency. There was a significant relationship between Masaoka stage and WHO type (P < 0.05); the numbers of advanced-stage thymoma progressively increased in WHO type B3–C. Eight patients in each group had recurrent disease, with greater recurrence for WHO types B3–C and stage III–IV tumors. Five-year disease-free survival (DFS) was not different between groups (P = 0.3906); however, survival for patients with stage III–IV thymomas (47 %) was significantly worse than that for patients with stage I and II tumors (97.5 and 94.1 %, respectively; P < 0.0001). Based on multivariate analysis, both Masaoka stage and WHO type were significant predictors of thymoma patient survival.
Conclusions
These results demonstrate the safety and substantially decreased invasiveness of TT for thymoma. The oncological results were comparable between the TT and OT groups. Furthermore, Masaoka stage III–IV and WHO B3–C were revealed as independent prognostic factors for DFS.
Similar content being viewed by others
References
Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492
Kimura T, Inoue M, Kadota Y, Shiono H, Shintani Y, Nakagiri T (2013) The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg 44:214–218
Ye B, Li W, Ge XX, Feng J, Ji CY, Cheng M, Tantai JC, Zhao H (2014) Surgical treatment of early-stage thymomas: robot-assisted thoracoscopic surgery versus transsternal thymectomy. Surg Endosc 28:122–126
Odaka M, Akiba T, Yabe M, Hiramatsu M, Matsudaira H, Hirano J, Morikawa T (2010) Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma. Eur J Cardiothorac Surg 37:824–826
Liu TJ, Lin MW, Hsieh MS, Kao MW, Chen KC, Chang CC, Kuo SW, Huang PM, Hsu HH, Chen JS, Lai HS, Lee JM (2014) Video-assisted thoracoscopic surgical thymectomy to treat early thymoma: a comparison with the conventional transsternal approach. Ann Surg Oncol 21:322–328
Chao YK, Liu YH, Hsieh MJ, Wu YC, Chen TP, Lu MS, Lu HI, Liu HP (2015) Long-term outcomes after thoracoscopic resection of stage I and II thymoma: a propensity-matched study. Ann Surg Oncol 22:1371–1376
Pennathur A, Qureshi I, Schuchert MJ, Dhupar R, Ferson PF, Gooding WE, Christie NA, Gilbert S, Shende M, Awais O, Greenberger JS, Landreneau RJ, Luketich JD (2011) Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg 141:694–701
Ye B, Tantai JC, Ge XX, Li W, Feng J, Cheng M, Shi JX, Zhao H (2014) Surgical techniques for early-stage thymoma: video-assisted thoracoscopic thymectomy versus transsternal thymectomy. J Thorac Cardiovasc Surg 147:1599–1603
Manoly I, Whistance RN, Sreekumar R, Khawaja S, Horton JM, Khan AZ, Casali G, Thorpe JA, Amer K, Woo E (2014) Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg 45:187–193
Sakamaki Y, Oda T, Kanazawa G, Shimokawa T, Kido T, Shiono H (2014) Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma. J Thorac Cardiovasc Surg 148:1230–1237
Tagawa T, Yamasaki N, Tsuchiya T, Miyazaki T, Morino S, Akamine S, Nagayasu T (2014) Thoracoscopic versus transsternal resection for early stage thymoma: long-term outcomes. Surg Today 44:2275–2280
Toker A, Erus S, Ziyade S, Ozkan B, Tanju S (2013) It is feasible to operate on pathological Masaoka stage I and II thymoma patients with video-assisted thoracoscopy: analysis of factors for a successful resection. Surg Endosc 27:1555–1560
Singhal S, Kaiser LR (2003) Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76:1635–1641
Tseng YC, Hsieh CC, Huang HY, Huang CS, Hsu WH, Huang BS, Huang MH, Hsu HS (2013) Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol 8:952–958
Kohman LJ (1997) Controversies in the management of malignant thymoma. Chest 112:296S–300S
Sakamaki Y, Kido T, Yasukawa M (2008) Alternative choices of total and partial thymectomy in video-assisted resection of noninvasive thymomas. Surg Endosc 22:1272–1277
Lee HS, Kim ST, Lee J, Choi YS, Han JH, Ahn YC, Lee KS, Ahn JS, Ahn MJ, Kim K, Shim YM, Kim J, Park K (2007) A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer 97:22–28
Hamaji M (2014) Does adjuvant chemotherapy following complete resection also have a significant effect on overall survival of thymic epithelial tumours? Eur J Cardiothorac Surg 48:340. doi:10.1093/ejcts/ezu480 Epub 2014 Dec 11
Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK (2001) New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95:420–429
Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15:3093–3099
Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol 12:1164–1168
Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, Shin HJ, Ki KH, Wimberly A, Pisters KM, Schrump D, Gregurich MA, Cox JD, Roth JA, Hong WK (1998) A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129:100–104
Attaran S, McCormack D, Pilling J, Harrison-Phipps K (2012) Which stages of thymoma benefit from adjuvant chemotherapy post-thymectomy? Interact CardioVasc Thorac Surg 15:273–275
Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC (2000) Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 46:927–933
Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y (2004) WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183–1188
Kondo K, Monden Y (2005) Myasthenia gravis appearing after thymectomy for thymoma. Eur J Cardiothorac Surg 28:22–25
Kirschner PA (2001) Reoperation on the thymus. A critique. Chest Surg Clin N Am 11(2):439–445
Pompeo E, Nofroni I, Iavicoli N, Mineo TC (2000) Thoracoscopic completion thymectomy in refractory nonthymomatous myasthenia. Ann Thorac Surg 70:918–923
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Makoto Odaka, Takamasa Shibasaki, Daiki Kato, Shohei Mori, Hisatoshi Asano, Makoto Yamashita, and Toshiaki Morikawa have no conflict of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Odaka, M., Shibasaki, T., Kato, D. et al. Comparison of oncological results for early- and advanced-stage thymomas: thoracoscopic thymectomy versus open thymectomy. Surg Endosc 31, 734–742 (2017). https://doi.org/10.1007/s00464-016-5027-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-016-5027-2